Clinical Trials Directory

Trials / Completed

CompletedNCT00877695

Motiv82Change: an HIV Prevention Study for Young Latino Men

Young Hispanic Men "Entre Culturas": Navigating Culture, Identity and HIV Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Nova Southeastern University · Academic / Other
Sex
Male
Age
18 Years – 29 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to develop and pilot test a culturally and developmentally tailored Motivational Enhancement Intervention (MEI) to reduce risky sex (unprotected anal sex and multiple partners) among young Hispanic men who have sex with men (YHMSM).

Detailed description

Stage 1, divided into Stage 1a and Stage 1b, focuses on development, refinement, and pilot testing of interventions. The formative research leading to and including intervention development is completed in Stage 1a. A pilot study to provide acceptability/feasibility data and obtain effect size estimates of the intervention's strength in changing a desired outcome is conducted in Stage 1b. If Stage 1b results are "promising," the intervention moves to full scale efficacy testing in Stage 2 using the classic experimental design of a randomized control trial (RCT). The intervention is ready for Stage 3 effectiveness testing only after its efficacy has been demonstrated in at least two Stage 2 trials.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEntre Culturas: Navigating Culture, Identity, and HIV RiskA pilot test of a culturally and developmentally tailored MEI to reduce risky sex (unprotected anal sex and multiple partners) among young Hispanic men who have sex with men (YHMSM) to be delivered face-to-face (FtF) and through the Internet using a real-time implementation approach. A tailored MEI for two delivery modalities, and a health education control (HEALTH) comparable in time and number of sessions. We will test the MEI's acceptability and feasibility, obtain effect size estimates of the intervention's strength to reduce risky sex, and determine if it is ready for efficacy testing.

Timeline

Start date
2010-08-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2009-04-08
Last updated
2013-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00877695. Inclusion in this directory is not an endorsement.